Merck & Co. agreed Friday to pay $100 million in product liability lawsuits that claimed its birth control product NuvaRing caused blood clots that led in some instances to fatal heart attacks, Reuters reports.
NuvaRing, a vaginal ring that acts as a hormonal contraceptive and contains estrogen and progestin as commonly found in birth control pills, has been associated with an increased risk of developing blood clots that can cause heart attack, stroke, or sudden death.
Merck, which is the second-largest drug manufacturer in the U.S., denied any fault under the agreement. But 3,000 people are eligible to participate in the settlement, and 95% of those women will have to participate in order for the deal to take effect.
Merck is getting off easy compared with similar birth control company settlements. Bayer paid nearly $1.6 billion to settle thousands of lawsuits last year surrounding its Yaz and Yazmin birth control pills, which plaintiffs claimed also led to blood clots, heart attacks, and strokes.
- Here’s How Effective the Original Vaccines Are Against Omicron
- The Promise—And Possible Perils—of Editing What We Say Online
- How Trump Survived Decades of Legal Trouble: Deny, Deflect, Delay, and Don't Put Anything in Writing
- Flint Is Still Shaken by its Water Crisis—and Residents Are Experiencing Long-Term Mental-Health Issues
- A Beer Shortage Is Brewing. A Volcano Is Partly to Blame
- How Fasting Can—and Can't—Improve Gut Health
- Cities Keep Enforcing Curfews for Teens, Despite Evidence They Don't Stop Crime
- Joe Manchin’s Red Tape Reform Could Supercharge Renewable Energy in the U.S.
- Column: We Should Talk More About What a Brilliant Actor Marilyn Monroe Was